Since the COVID-19 vaccine has been approved for sickle cell warriors, there have been a lot of questions about the vaccine. Sick Cells sat down virtually with two sickle cell warriors who received both doses of the vaccine to talk about their experience.
Since March 2020, the world has been coping with a “new normal” of the COVID-19 pandemic. Hear what advocate and intern Rafia has to say about life full of changing guidelines on masking, social distancing, and quarantine.
This year, Sick Cells is celebrating Black History Month with its #YourBlackHistory series which aims to highlight the voices of Black sickle cell warriors, caregivers and advocates who are making history today through their advocacy work, commitment to service, and devotion to improving the lives of those in the community.
As part of the series, we’re spotlighting Mapillar Dahn — president and founder of MTS Sickle Cell Foundation, Inc. and the mother of three children who live with sickle cell — and her perspective on the sickle cell disease community’s unique needs.
The goal of Your Black History Month is to amplify the voices of Black sickle cell warriors, caregivers and advocates who are making history, today, through their advocacy work, commitment to service and devotion to improving the lives of those in the community. Throughout the month of February, Sick Cells will highlight five SCD advocates and their unique stories. #YourBlackHistoryMonth
This month, as we continue our series on complementary therapies, Sick Cells spoke with Sam Rodgers-Melnick, MT-BC, a music therapist and clinical researcher at University Hospitals Connor Integrative Health Network in Cleveland, OH.
Sick Cells took the time to speak with Jeffrey Zuttah and Terri Booker, Esq. Jeffrey is a sickle cell patient advocate and business professional who’s passionate about propelling the community forward at the local and national levels. Terri is a sickle cell advocate and lawyer working as a civil servant to her community of Philadelphia. As votes continue to pour in ahead of Election Day (Tuesday, November 3), they shared why they choose to vote.
After a December 2019 article on the cost of the two most recent sickle cell disease (SCD) treatments was highly criticized by members of the community, it became clear that knowledge on the disease, its types, and complications was disparate.